Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Pediatric Asthma Guidelines-Based Care, Omalizumab, and Other Potential Biologic Agents

Pediatric Asthma Guidelines-Based Care, Omalizumab, and Other Potential Biologic Agents IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA Huffaker, M., Phipatanakul, W. 2015; 35 (1): 129-+

Abstract

Over the past several decades, the evidence supporting rational pediatric asthma management has grown considerably. As more is learned about the various phenotypes of asthma, the complexity of management will continue to grow. This article focuses on the evidence supporting the current guidelines-based pediatric asthma management and explores the future of asthma management with respect to phenotypic heterogeneity and biologics.

View details for DOI 10.1016/j.iac.2014.09.005

View details for Web of Science ID 000346686700009

View details for PubMedID 25459581

View details for PubMedCentralID PMC4254501